A Antigen PEGylated (Highly Pure)

<strong>A Antigen PEGylated (Highly Pure)</strong>_x000D_ <strong>Catalog number:</strong> B2010942_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 0.1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> 801 g/mol_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> GalNAcα(1-3)[Fucα(1-2)]Gal-β-PEG-trifluoroacetamide, A Antigen PEG-trifluoroacetamide_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Tang LSY, Covert E, Wilson E, Kottilil S. Chronic Hepatitis B Infection: A Review JAMA. 2018 May 1;319(17):1802-1813._x000D_ 2: Wenande E, Garvey LH. Immediate-type hypersensitivity to polyethylene glycols: a review Clin Exp Allergy. 2016 Jul;46(7):907-22._x000D_ 3: Hu C, Song Y, Tang C, Li M, Liu J, Liu J, Liao M, Zhou F, Zhang YY, Zhou Y. Effect of Pegylated Interferon Plus Tenofovir Combination on Higher Hepatitis B Surface Antigen Loss in Treatment-naive Patients With Hepatitis B e Antigen -positive Chronic Hepatitis B: A Real-world Experience Clin Ther. 2021 Mar;43(3):572-581.e3._x000D_ 4: Wang Y, Zhang L, Xu Z, Miao L, Huang L. mRNA Vaccine with Antigen-Specific Checkpoint Blockade Induces an Enhanced Immune Response against Established Melanoma Mol Ther. 2018 Feb 7;26(2):420-434._x000D_ 5: Lee JH, Lee YB, Cho EJ, Yu SJ, Yoon JH, Kim YJ. Entecavir Plus Pegylated Interferon and Sequential Hepatitis B Virus Vaccination Increases Hepatitis B Surface Antigen Seroclearance: A Randomized Controlled Proof-of-Concept Study Clin Infect Dis. 2021 Nov 2;73(9):e3308-e3316._x000D_ 6: Bahardoust M, Mokhtare M, Barati M, Bagheri-Hosseinabadi Z, Karimi Behnagh A, Keyvani H, Agah S. A randomized controlled trial of pegylated interferon-alpha with tenofovir disoproxil fumarate for hepatitis B e antigen-negative chronic hepatitis B: A 48-week follow-up study J Infect Chemother. 2020 Dec;26(12):1265-1271._x000D_ 7: Klimek L, Novak N, Cabanillas B, Jutel M, Bousquet J, Akdis CA. Allergenic components of the mRNA-1273 vaccine for COVID-19: Possible involvement of polyethylene glycol and IgG-mediated complement activation Allergy. 2021 Nov;76(11):3307-3313._x000D_ 8: Cornberg M, Wong VW, Locarnini S, Brunetto M, Janssen HLA, Chan HL. The role of quantitative hepatitis B surface antigen revisited J Hepatol. 2017 Feb;66(2):398-411._x000D_ 9: Ma Y, Wang J, Xiong F, Lu J. Extended duration therapy regimens based on Pegylated interferon for chronic hepatitis B patients focusing on hepatitis B surface antigen loss: A systematic review and meta-analysis Infect Genet Evol. 2020 Nov;85:104492._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/29281787">10: Yeh PY, Chen YR, Wang CF, Chang YC. Promoting Multivalent Antibody-Antigen Interactions by Tethering Antibody Molecules on a PEGylated Dendrimer-Supported Lipid Bilayer Biomacromolecules. 2018 Feb 12;19(2):426-437. </a>_x000D_ _x000D_ <strong>Products Related to A Antigen PEGylated (Highly Pure)</strong><a href="https://moleculardepot.com/product-category/Chemicals/">: Chemicals</a>